Systematic profiling of a lipid metabolism-derived signature guides risk-stratification and therapeutic strategies in hepatocellular carcinoma

Clin Transl Med. 2023 May;13(5):e1254. doi: 10.1002/ctm2.1254.

Authors

Zhengyi Zhu¹, Yuyan Chen¹, Jinkun Xia¹, Jinglin Wang^{1

2}, Haozhen Ren^{1

2}

Affiliations

¹ Department of Hepatobiliary Surgery, Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, China.
² Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Carcinoma, Hepatocellular* / genetics
Carcinoma, Hepatocellular* / pathology
Carcinoma, Hepatocellular* / therapy
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Lipid Metabolism
Liver Neoplasms* / genetics
Liver Neoplasms* / pathology
Liver Neoplasms* / therapy